Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 163 results.
User Information
Export Records
  1. 1.   Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
  2. Kundu, Biswajit; Dvorácskó, Szabolcs; Basu, Abhishek; Pommerolle, Lenny; Kim, Kyu Ah; Wood, Casey M; Gibbs, Eve; Behee, Madeline; Tarasova,Nadya; Cinar, Resat; Iyer, Malliga R
  3. Molecules (Basel, Switzerland). 2024, Jun 26; 29(13):
  1. 2.   Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
  2. Eldridge, Sandy; Scuteri, Arianna; Jones, Eugenia M. C.; Cavaletti, Guido; Guo, Liang; Glaze, Elizabeth
  3. Toxics. 2021, Nov 11; 9(11):
  1. 3.   Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family
  2. Brown, Kevin M; Xu, Mai; Sargen, Michael; Jang,Hyunbum; Zhang,Mingzhen; Zhang, Tongwu; Zhu, Bin; Jones, Kristie; Kim, Jung; Mendoza, Laura; Hayward, Nicholas K; Tucker, Margaret A; Goldstein, Alisa M; Yang, Xiaohong Rose; Stewart, Douglas R; Hicks, Belynda; Consonni, Dario; Pesatori, Angela C; Fargnoli, Maria Concetta; Peris, Ketty; Stratigos, Alex; Menin, Chiara; Ghiorzo, Paola; Puig, Susana; Nagore, Eduardo; Andresson,Thorkell; Nussinov,Ruth; Calista, Donato; Landi, Maria Teresa
  3. Familial cancer. 2021, Jul 03;
  1. 4.   Cytokines: From Clinical Significance to Quantification
  2. Liu, Chao; Chu, Dewei; Kalantar-Zadeh, Kourosh; George, Jacob; Young,Howard; Liu, Guozhen
  3. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2021, Jun 10;
  1. 5.   Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
  2. Dobrovolskaia,Marina
  3. Molecules (Basel, Switzerland). 2019, Dec; 24(24):
  1. 6.   Nanoparticle physicochemical properties determine the activation of intracellular complement
  2. Ilinskaya, Anna N.; Shah, Ankit; Enciso, Alan E.; Chan,King; Kaczmarczyk,Jan; Blonder,Josip; Simanek, Eric E.; Dobrovolskaia,Marina
  3. Nanomedicine : nanotechnology, biology, and medicine. 2019, APR; 17: 266-275.
  1. 7.   PLK4 is a microtubule-associated protein that self assembles promoting de novo MTOC formation
  2. Gouveia, Susana Montenegro; Zitouni, Sihem; Kong, Dong; Duarte, Paulo; Gomes, Beatriz Ferreira; Sousa, Ana Laura; Tranfield, Erin M; Hyman, Anthony; Loncarek, Jadranka; Bettencourt-Dias, Monica
  3. Journal of cell science. 2019, Feb; 132(4): pii: jcs.219501.
  1. 8.   Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations
  2. Cedrone, Edward; Neun, Barry; Rodriguez, Jamie; Vermilya, Alison; Clogston, Jeffrey; McNeil, Scott; Barenholz, Yechezkel; Szebeni, Janos; Dobrovolskaia, Marina
  3. Molecules . 2018, Jan; 23(1): pii: E12.
  1. 9.   Prediction of pharmacokinetic and toxicological parameters of a 4-phenylcoumarin isolated from geopropolis: in silico and in vitro approaches
  2. da Cunha, M. G.; Franco, G. C.; Franchin, M.; Beutler, John; de Alencar, S. M.; Ikegaki, M.; Rosalen, P. L.
  3. Toxicology Letters. 2016, Nov 30; 263: 6-10.
  1. 10.   Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab
  2. Gardner, E. R.; Kelly, M.; Springman, E.; Lee, K. J.; Li, H. Q.; Moore, W.; Figg, W. D.
  3. Investigational New Drugs. 2012, Feb; 30(1): 90-97.
  1. 11.   The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability
  2. Jiang, J. Y.; Ablan, S. D.; Derebail, S.; Hercik, K.; Soheilian, F.; Thomas, J. A.; Tang, S. X.; Hewlett, I.; Nagashima, K.; Gorelick, R. J.; Freed, E. O.; Levin, J. G.
  3. Virology. 2011, Dec; 421(2): 253-265.
  1. 12.   Ambiguities in applying traditional Limulus Amebocyte Lysate tests to quantify endotoxin in nanoparticle formulations
  2. Dobrovolskaia, M. A.; Neun, B. W.; Clogston, J. D.; Ding, H.; Ljubimova, J.; McNeil, S. E.
  3. Nanomedicine. 2010, Jun; 5(4): 555-562.
  1. 13.   Prevalidation of the Rat CFU-GM Assay for In Vitro Toxicology Applications
  2. Pessina, A.; Bonomi, A.; Cavicchini, L.; Albella, B.; Cerrato, L.; Parent-Massin, D.; Sibiril, Y.; Parchment, R.; Behrsing, H.; Verderio, P.; Pizzamiglio, S.; Giangreco, M.; Baglio, C.; Cocce, V.; Sisto, F.; Gribaldo, L.
  3. Atla-Alternatives to Laboratory Animals. 2010, May; 38(2): 105-117.
  1. 14.   Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors
  2. Khan, T.; Stauffer, J. K.; Williams, R.; Hixon, J. A.; Salcedo, R.; Lincoln, E.; Back, T. C.; Powell, D.; Lockett, S.; Arnold, A. C.; Sayers, T. J.; Wigginton, J. M.
  3. Journal of Immunology. 2006, MAY 15; 176(10): 6302-6312.
  1. 15.   RAP uses a histidine switch to regulate its interaction with LRP in the ER and Golgi
  2. Lee, D.; Walsh, J. D.; Mikhailenko, I.; Yu, P.; Migliorini, M.; Wu, Y. B.; Krueger, S.; Curtis, J. E.; Harris, B.; Lockett, S.; Blacklow, S. C.; Strickl, D. K.; Wang, Y. X.
  3. Molecular Cell. 2006, MAY 5; 22(3): 423-430.
  1. 16.   Antibody-based inhibitors of HIV infection
  2. Choudhry, V.; Zhang, M. Y.; Dimitrova, D.; Prabakaran, P.; Dimitrov, A. S.; Fouts, T. R.; Dimitrov, D. S.
  3. Expert Opinion on Biological Therapy. 2006, MAY; 6(5): 523-531.
  1. 17.   Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets
  2. Urzua, U.; Roby, K. F.; Gangi, L. M.; Cherry, J. M.; Powell, J. I.; Munroe, D. J.
  3. Journal of Cellular Physiology. 2006, MAR; 206(3): 594-602.
  1. 18.   Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration
  2. Melcon, G.; Kozlov, S.; Cutler, D. A.; Sullivan, T.; Hernandez, L.; Zhao, P.; Mitchell, S.; Nader, G.; Bakay, M.; Rottman, J. N.; Hoffman, E. P.; Stewart, C. L.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 637-651.
  1. 19.   IL-3-mediated TNF production is necessary for mast cell development
  2. Wright, H. V.; Bailey, D.; Kashyap, M.; Kepley, C. L.; Drutskaya, M. S.; Nedospasov, S. A.; Ryan, J. J.
  3. Journal of Immunology. 2006, FEB 15; 176(4): 2114-2121.
  1. 20.   PABA/NO as an anticancer lead: Analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity
  2. Saavedra, J. E.; Srinivasan, A.; Buzard, G. S.; Davies, K. M.; Waterhouse, D. J.; Inami, K.; Wilde, T. C.; Citro, M. L.; Cuellar, M.; Deschamps, J. R.; Parrish, D.; Shami, P. J.; Findlay, V. J.; Townsend, D. M.; Tew, K. D.; Singh, S.; Jia, L.; Ji, X. H.; Keefer, L. K.
  3. Journal of Medicinal Chemistry. 2006, FEB 9; 49(3): 1157-1164.
  1. 21.   Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma
  2. Khan, T.; Hixon, J. A.; Stauffer, J. K.; Lincoln, E.; Back, T. C.; Brenner, J.; Lockett, S.; Nagashima, K.; Powell, D.; Wigginton, J. M.
  3. Journal of the National Cancer Institute. 2006, FEB 1; 98(3): 190-202.
  1. 22.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
  1. 23.   Human alpha-defensins block papillomavirus infection
  2. Buck, C. B.; Day, P. M.; Thompson, C. D.; Lubkowski, J.; Lu, W. Y.; Lowy, D. R.; Schiller, J. T.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, JAN 31; 103(5): 1516-1521.
  1. 24.   Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors
  2. Stauffer, J. K.; Khan, T.; Salcedo, R.; Hixon, J. A.; Lincoln, E.; Back, T. C.; Wigginton, J. M.
  3. Journal of Immunotherapy. 2006, MAR-APR; 29(2): 151-164.
  1. 25.   Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis
  2. Dorjsuren, D.; Burnette, A.; Gray, G. N.; Chen, X. L.; Zhu, W. M.; Roberts, P. E.; Currens, M. J.; Shoemaker, R. H.; Ricciardi, R. P.; Sei, S.
  3. Antiviral Research. 2006, JAN; 69(1): 9-23.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel